Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
The EIT Food Biotech Proof of Concept call helps biotech start-ups overcome two critical development gaps through Route 1 (Validation) for technologies at TRL 4–6 and Route 2 (Demonstrator) for technologies at TRL 7–9.
A ‘Proof of Concept’ is a small-scale project that tests whether a technology, product or service works in a real-world setting and can meet the needs of a potential customer. For biotech start-ups, this stage is critical because many promising innovations fail before they reach market due to two distinct ‘valleys of death’.
To address these challenges, the EIT Food Biotech Proof of Concept funding call comprises two funding routes, each targeting a different valley of death and stage of innovation maturity.
Together, the two routes provide a pathway for biotech start-ups to access support at the stage most relevant to their development. Through this call, EIT Food aims to foster collaboration between start-ups and corporate partners to validate technologies, test commercial assumptions and generate evidence for future scale-up and investment. This includes where relevant, facilitating access to pilot facilities, laboratories and other specialised infrastructure held by Alliance members – resources that start-ups often cannot access or afford on their own. Projects should generate practical evidence, reduce technical and commercial risk, and establish a clear pathway towards further development, pilot expansion and market adoption.
For Route 1: The maximum funding allocated to this route is up to €180.000. Recipients will receive a subgrant by EIT Food to fund their cost. The maximum funding available per application is € 60 000 00 (lump sum).
Funds are primarily directed toward technical validation, laboratory testing, covering the costs of using research infrastructures, and mentoring to establish initial industrial partnerships.
For Route 2: The maximum funding allocated to this route is up to €750.000. The maximum funding available per application is €250.000. It focus on Larger-scale demonstration, commercial scaling, co-financing, and deep industrial partnerships aimed at reaching immediate market deployment.
The 100% funding rate applies to both Route 1 (Validation) and Route 2 (Demonstrator). For both pathways, the financial mechanism is delivered as a non-dilutive, 100% sub-grant covering the startup’s eligible operational costs:
Differences Between the Routes
In order to be eligible for funding, the applicant must
Applicants do not need to be EIT Food or Biotech Alliance members, but they must apply with a committed Biotech Alliance corporate partner that meets the call requirements and supports the proposed PoC through a signed Letter of Intent (LoI). The corporate project partner is not a beneficiary and receives no funding.
Route 1 and Route 2are mono-beneficiary calls for start-ups only. Each proposal is submitted by one single entity only (a small or micro enterprise), which is the only beneficiary and the only entity that can receive the subgrant.
Proposals with more than one beneficiary are ineligible.EIT Food provides a matchmaking platform through FoodHIVE to help start-ups connect with potential corporate partners within the ecosystem (to access, please register here).
EIT Community RIS Hub Cyprus
Dr. Styliani Petroudi
EIT Community Officer Cyprus
Contact email: cyprus@eitcommunity.eu
If you have any questions about this call, please contact the call manager Mariana Fazenda at biotechalliance@eitfood.eu.